Validates the use of the RAPID score for predicting mortality in pleural infections, directly informing the management of patients undergoing pleural interventions like chest tubes and medical thoracoscopy.
Abstract
Pleural fluid supernatant cfDNA should be routinely preserved and can already be used selectively for molecular profiling in NSCLC, while broader implementation requires prospective clinical validation.
Keep reading
N opens the next oneUltrasound estimation of pleural fluid volume is a core procedural skill for thoracentesis and chest tube placement, making this directly relevant to IP practice.
Directly impacts pleural management and staging by maximizing the diagnostic yield of routine thoracentesis for molecular testing in malignancy.
Relevant to pleural disease management and post-procedural care of trapped or non-expandable lungs.
Provides useful risk stratification tools for managing secondary spontaneous pneumothorax patients who often require IP intervention.
Relevant for multidisciplinary management of malignant pleural mesothelioma, though radiotherapy is primarily managed by radiation oncology.